Health Care & Life Sciences » Biotechnology | MabVax Therapeutics Holdings Inc.

MabVax Therapeutics Holdings Inc.

MabVax Therapeutics Holdings Inc.
Stock Exchange NASDAQ Stock Market
EPS
$10.04
Market Cap
$4.03 M
Shares Outstanding
8.96 M
Public Float
8.19 M

Profile

Address
11535 Sorrento Valley Road
San Diego California 92121
United States
Employees -
Website http://www.mabvax.com
Updated 09/14/2018
MabVax Therapeutics Holdings, Inc. is a clinical stage biopharmaceutical company, which focuses on discovering and developing innovative vaccine and monoclonal antibody-based therapeutics for the diagnosis and treatment of cancer. The company was founded on July 8, 2014 and is headquartered in San Diego, CA. .

Financials

View All

John David Hansen
Chairman, President & Chief Executive Officer
Gregory P. Hanson
Chief Financial Officer & Director